Literature DB >> 17074466

DTNBP1 genotype influences cognitive decline in schizophrenia.

Katherine E Burdick1, Terry E Goldberg, Birgit Funke, John A Bates, Todd Lencz, Raju Kucherlapati, Anil K Malhotra.   

Abstract

OBJECTIVE: Intellectual decline is common in schizophrenia and predicts functional outcome. While many patients undergo intellectual decline that typically predates the onset of symptoms, few studies have investigated the underlying mechanism through which this occurs. The current study assessed the relationship between intellectual decline in schizophrenia and genetic variation in dysbindin-1 (DTNBP1).
METHODS: We assessed cognitive decline in 183 Caucasian patients with schizophrenia using a proxy measure of premorbid IQ with which current general cognitive ability (g) was compared. We then tested for a relationship between the risk haplotype identified in previous work (CTCTAC) and intellectual decline.
RESULTS: We found that carriers of the CTCTAC haplotype, demonstrated a significantly greater decline in IQ as compared with non-carriers (p=0.05).
CONCLUSIONS: These data suggest that DTNBP1 influences the severity of intellectual decline in schizophrenia and may represent one underlying cause for heterogeneity in cognitive course.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074466      PMCID: PMC1828039          DOI: 10.1016/j.schres.2006.09.008

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  17 in total

1.  Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder.

Authors:  T E Goldberg; E F Torrey; J M Gold; L B Bigelow; R D Ragland; E Taylor; D R Weinberger
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

2.  Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia.

Authors:  Abraham Reichenberg; Mark Weiser; Michael A Rapp; Jonathan Rabinowitz; Asaf Caspi; James Schmeidler; Haim Y Knobler; Gad Lubin; Daniela Nahon; Philip D Harvey; Michael Davidson
Journal:  Arch Gen Psychiatry       Date:  2005-12

3.  Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers.

Authors:  W S Kremen; L J Seidman; S V Faraone; M T Tsuang
Journal:  Biol Psychiatry       Date:  2001-09-15       Impact factor: 13.382

4.  Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

Authors:  T W Weickert; T E Goldberg; J M Gold; L B Bigelow; M F Egan; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2000-09

5.  Stability and course of neuropsychological deficits in schizophrenia.

Authors:  R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  2001-01

Review 6.  An update on the genetics of schizophrenia.

Authors:  Nadine Norton; Hywel J Williams; Michael J Owen
Journal:  Curr Opin Psychiatry       Date:  2006-03       Impact factor: 4.741

7.  Cognitive development in schizophrenia: follow-back from the first episode.

Authors:  Robert M Bilder; Gail Reiter; Jay Bates; Todd Lencz; Philip Szeszko; Robert S Goldman; Delbert Robinson; Jeffrey A Lieberman; John M Kane
Journal:  J Clin Exp Neuropsychol       Date:  2006-02       Impact factor: 2.475

8.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.

Authors:  Tadahiro Numakawa; Yuki Yagasaki; Tetsuya Ishimoto; Takeya Okada; Tatsuyo Suzuki; Nakao Iwata; Norio Ozaki; Takahisa Taguchi; Masahiko Tatsumi; Kunitoshi Kamijima; Richard E Straub; Daniel R Weinberger; Hiroshi Kunugi; Ryota Hashimoto
Journal:  Hum Mol Genet       Date:  2004-09-02       Impact factor: 6.150

9.  Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance.

Authors:  Rebecca Fuller; Peg Nopoulos; Stephan Arndt; Dan O'Leary; Beng-Choon Ho; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

10.  Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).

Authors:  N M Williams; A Preece; D W Morris; G Spurlock; N J Bray; M Stephens; N Norton; H Williams; M Clement; S Dwyer; C Curran; J Wilkinson; V Moskvina; J L Waddington; M Gill; A P Corvin; S Zammit; G Kirov; M J Owen; M C O'Donovan
Journal:  Arch Gen Psychiatry       Date:  2004-04
View more
  47 in total

1.  Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.

Authors:  Katherine H Karlsgodt; Karla Robleto; Heather Trantham-Davidson; Corey Jairl; Tyrone D Cannon; Antonieta Lavin; J David Jentsch
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

Review 2.  [Cognitive disorders in schizophrenic patients].

Authors:  H-P Volz; F Reischies; M Riedel
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

Review 3.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

4.  Brief report: no association between premorbid adjustment in adult-onset schizophrenia and genetic variation in Dysbindin.

Authors:  Frederike Schirmbeck; Alexander Georgi; Jana Strohmaier; Christine Schmael; Katja V Boesshenz; Thomas W Mühleisen; Stefan Herms; Per Hoffmann; Rami Abou Jamra; Johannes Schumacher; Wolfgang Maier; Peter Propping; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Thomas G Schulze
Journal:  J Autism Dev Disord       Date:  2008-05-13

Review 5.  Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature.

Authors:  Ayman H Fanous; Kenneth S Kendler
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

6.  Can genomics help usher schizophrenia into the age of RDoC and DSM-6?

Authors:  Ayman H Fanous
Journal:  Schizophr Bull       Date:  2015-05       Impact factor: 9.306

7.  A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.

Authors:  Jana Strohmaier; Josef Frank; Jens R Wendland; Johannes Schumacher; Rami Abou Jamra; Jens Treutlein; Vanessa Nieratschker; René Breuer; Manuel Mattheisen; Stefan Herms; Thomas W Mühleisen; Wolfgang Maier; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Thomas G Schulze
Journal:  Schizophr Res       Date:  2010-01-18       Impact factor: 4.939

8.  DTNBP1 is associated with imaging phenotypes in schizophrenia.

Authors:  Katherine L Narr; Philip R Szeszko; Todd Lencz; Roger P Woods; Liberty S Hamilton; Owen Phillips; Delbert Robinson; Katherine E Burdick; Pamela DeRosse; Raju Kucherlapati; Paul M Thompson; Arthur W Toga; Anil K Malhotra; Robert M Bilder
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

9.  Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.

Authors:  Ilja Spellmann; Norbert Müller; Richard Musil; Peter Zill; Anette Douhet; Sandra Dehning; Anja Cerovecki; Brigitta Bondy; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03-17       Impact factor: 5.270

10.  The effects of a DTNBP1 gene variant on attention networks: an fMRI study.

Authors:  Markus Thimm; Axel Krug; Thilo Kellermann; Valentin Markov; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Markus M Nöthen; Marcella Rietschel; Tilo Kircher
Journal:  Behav Brain Funct       Date:  2010-09-16       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.